The United States pharmaceutical industry is one of the most advanced and competitive healthcare markets in … How Market Access Challenges Detail Pharma GrowthRead more
clinical trials
Why Many Drugs Fail Despite Positive Trial Results
Over 90 percent of drugs that show promise in early-phase clinical trials fail to reach the … Why Many Drugs Fail Despite Positive Trial ResultsRead more
Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem
When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more
Why Pharma Companies Struggle With Trial Participant Retention
Nearly 30 percent of clinical trial participants withdraw before study completion in certain therapeutic areas, according … Why Pharma Companies Struggle With Trial Participant RetentionRead more
Top Clinical Trial Challenges No One in Pharma Talks About
The U.S. pharmaceutical industry invests heavily in marketing, with estimates from Statista showing that spending on … Top Clinical Trial Challenges No One in Pharma Talks AboutRead more
Why Many Biotech Startups Never Make It Past Early Trials
Over 90% of biotech startups never advance beyond early clinical trials, a statistic that underscores the … Why Many Biotech Startups Never Make It Past Early TrialsRead more
Why Phase II Clinical Trials Are the Graveyard of Drug Development
Nearly 60 percent of drug candidates that enter Phase II clinical trials never advance to Phase … Why Phase II Clinical Trials Are the Graveyard of Drug DevelopmentRead more
What Happens When Pharma Ignores Real-World Evidence
In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more
The Real Reasons Promising Drugs Fail Before Phase II
Drug development is one of the most capital-intensive and high-risk sectors in the pharmaceutical industry. While … The Real Reasons Promising Drugs Fail Before Phase IIRead more